Therapeutic value of levocabastine eye drops in the treatment of allergic conjunctivitis, a comparative study versus antazoline-tetrahydrozoline eye drops / (Record no. 3569)

MARC details
000 -LEADER
fixed length control field 01992nam a22002417a 4500
003 - CONTROL NUMBER IDENTIFIER
control field DOH
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20210317092935.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 210317b ||||| |||| 00| 0 eng d
245 00 - TITLE STATEMENT
Title Therapeutic value of levocabastine eye drops in the treatment of allergic conjunctivitis, a comparative study versus antazoline-tetrahydrozoline eye drops /
Statement of responsibility, etc. Jacinto U. Dy-Liacco [and four others]
520 3# - SUMMARY, ETC.
Summary, etc. This double-blind comparative study was done to assess and compare the efficacy and safety of levocabastine eye drops in Filipino patients having allergic conjunctivitis versus those of antazoline-tetrahydrozoline eye drops. A total of 54 children and adult were randomized to receive either levocabastine eye drops 0.5 mg/mL administered twice daily or antazoline (0.5 mg/mL)- tetrahydrozoline (0.4 mg/mL) administered four times a day with a treatment duration of two weeks. The patients were classified, depending on the severity of the signs and symptoms of their allergic conjunctivitis, into three categories namely: mild, moderate, and severe. Global evaluation of treatment was rated as excellent, good, moderate or unsatisfactory. Overall therapeutic response was found to be comparable for the two treatment groups. There were also no significant differences between the adverse reactions arising from both drugs. In conclusion, levocabastine is as safe and effective as antazoline-tetrahydrozoline for the treatment of allergic conjunctivitis with its additional advantages of having a faster onset of action and lesser frequency of administration.
580 ## - LINKING ENTRY COMPLEXITY NOTE
Linking entry complexity note Acta Medica Philippina,1997 33 ( 3 ) pages 157-164
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lubricant Eye Drops
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ophthalmic Solutions
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Levocabastine
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Antazoline-tetrahydrozoline
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dy-Liacco, Jacinto U.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Siong, Ruben Lim B.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Eltanal, Ma. Antonette
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kabamalan, Ma. Gracia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Valencia, Cynthia I.
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
999 ## -
-- 3569
-- 3569
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
    National Library of Medicine     DOH Central Library DOH Central Library Electronic Resource Section 03/17/2021   J000168 D0001J000168 03/17/2021 03/17/2021 Journal Article